Phase 3 SHINE results show postive results for IMBRUVICA (ibrutinib) in Mantle Cell Lymphoma Ruchika Sharma5 Jun 2022 3:00 PM ISTMCL is a type of aggressive, rare non-Hodgkin lymphoma (NHL) that is incurable and difficult to treat.
Hypomethylating agents Could Activate "Sleeping" Cancer-Causing Gene: NEJM Medical Dialogues Editorial Team26 May 2022 9:15 PM ISTChina: Hypomethylating agents (HMA) are currently used as a first-line treatment for patients with myelodysplastic syndrome (MDS) -and increasingly in...
FDA Approves tapinarof cream- first nonsteroidal treatment for plaque psoriasis Dr. Kamal Kant Kohli26 May 2022 10:00 AM ISTThe Food and Drugs Administration has approved Vtama cream for treating plaque psoriasis with varying severity. The approval was announced by...
Should surgery be opted for Achilles Tendon rupture? Study says no benefit Medical Dialogues Editorial Team18 May 2022 7:00 PM ISTNorway: In a new study conducted by Stale B. Myhrvold it was seen that at 12 months, surgery (minimally invasive surgery or open repair) was not...
CV risk factors in childhood linked to hard CV disease outcomes in adulthood: NEJM MD Bureau7 May 2022 9:00 AM ISTPrevention of cardiovascular disease remains a major public health issue, with well-documented associations between cardiovascular risk factors in...
AstraZeneca, Daiichi Sankyo get USFDA nod for Enhertu for earlier breast cancer use Ruchika Sharma6 May 2022 5:08 PM ISTThe approval was granted under the FDA's Real-Time Oncology Review (RTOR) programme and converts the accelerated approval of Enhertu in later line...
Recombinant plant-based Covid-19 vaccine promising for infection control: NEJM Medical Dialogues Editorial Team6 May 2022 10:06 AM ISTCanada: In a new study conducted by Karen J. Hager and team, it was shown that the Coronavirus-like particles (CoVLP) + Adjuvant System 03 (AS03)...
Bayer gets USFDA priority review for darolutamide plus docetaxel to treat metastatic hormone-sensitive prostate cancer Ruchika Sharma4 May 2022 12:00 PM ISTDarolutamide is developed jointly by Bayer and Orion Corporation, a globally operating Finnish pharmaceutical company.
Nasal High-Flow therapy Ups Intubation Success in First Attempt Among Neonates MD Bureau30 April 2022 12:45 PM ISTOpportunities for clinicians to become proficient in neonatal intubation have decreased over time. However, in a recent study, researchers reported...
Fourth dose of Pfizer vaccine may provide additional protection to elderly against severe disease: NEJM Medical Dialogues Editorial Team8 April 2022 10:00 AM ISTIsrael: A new study conducted by Yinon M. Bar-On and the team found that after the fourth dose of BNT162b2 vaccination, rates of confirmed SARS-CoV-2...
Tranexamic acid lowers bleeding in patients undergoing noncardiac surgery: NEJM Medical Dialogues Editorial Team6 April 2022 9:00 AM ISTAustralia: In a new study conducted by P.J. Devereaux and the team, it was found that the composite bleeding result was considerably lower with...
Trastuzumab deruxtecan decreases risk of disease progression and death in HER2 positive breast cancer: NEJM Medical Dialogues Editorial Team30 March 2022 9:15 AM ISTUSA: A new study published in The New England Journal of Medicine shows that patients with human epidermal growth factor receptor 2 (HER2)-positive...
